Clinical Trials in Atypical Parkinsonism: Quick Overview

Clinical Trials in Atypical Parkinsonism: Quick Overview

Atypical parkinsonism includes disorders like Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), Corticobasal Degeneration (CBD), and Dementia with Lewy Bodies (DLB). This post explores clinical trials for these conditions, highlighting advancements, challenges, and the implications for patients and caregivers.

The Landscape of Clinical Trials:

Progressive Supranuclear Palsy (PSP):

Recent Trials:
Tau-Targeted Therapies: Research focuses on tau proteinopathies. Drugs like tideglusib have aimed at inhibiting tau phosphorylation.
Microtubule Stabilizers: TPI-287 seeks to stabilize microtubules to prevent tau aggregates.

Challenges:
Accurate diagnosis and the lack of biomarkers complicate trials.

Multiple System Atrophy (MSA):

Recent Trials:
Immunotherapy: Drugs like PRX002 target alpha-synuclein, with mixed results.
Gene Therapy: Approaches include altering alpha-synuclein expression or degradation.

Challenges:
Heterogeneous symptoms between MSA subtypes make trial design complex.

Corticobasal Degeneration (CBD):

Trials:
Symptomatic Treatment: Botulinum toxin for dystonia, therapy for apraxia.
Tau-Modifying Therapies: Similar to PSP, focusing on tau pathology.

Challenges:
Rarity and diagnostic issues limit large-scale trials.

Dementia with Lewy Bodies (DLB):

Trials:
Cholinesterase Inhibitors and NMDA Antagonists: Standard treatments with ongoing refinement.
Neuroprotective Strategies: Early-stage trials like nilotinib focus on reducing alpha-synuclein.

Challenges:
Overlap with other neurodegenerative diseases complicates patient selection.

Common Challenges Across Disorders:

Diagnosis: Misdiagnosis delays trial participation.
Biomarkers: Lack of specific markers hinders tracking progression or treatment efficacy.
Patient Recruitment: Rarity and diagnostic ambiguity make it hard to gather enough participants.
Disease Heterogeneity: Varied presentations within disorders complicate treatment application.

Future Directions:

Precision Medicine: Personalized treatments based on genetics could improve outcomes.
Combination Therapies: Tackling multiple aspects of these diseases simultaneously.
Improved Diagnostics: Better imaging and biomarkers are essential for precise diagnosis.

Despite the challenges, clinical trials for atypical parkinsonism are advancing our understanding and hope for better treatments. Participation in trials can offer new therapeutic options and contribute to future research. For involvement or support in research, resources like ClinicalTrials.gov are invaluable.

Back to blog

Leave a public comment:

Please note, comments need to be approved before they are published.

  • The Unseen Struggle: Advocating for Someone with Atypical Parkinsonism

    The Unseen Struggle: Advocating for Someone wit...

    Living with atypical Parkinsonism is a complex and often misunderstood journey—not just for the person experiencing it, but for those who love and care for them. Unlike classic Parkinson’s disease,...

    The Unseen Struggle: Advocating for Someone wit...

    Living with atypical Parkinsonism is a complex and often misunderstood journey—not just for the person experiencing it, but for those who love and care for them. Unlike classic Parkinson’s disease,...

  • Board of Directors at Coleen Cunningham Foundation 2025

    Board of Directors at Coleen Cunningham Foundat...

    Introducing the backbone of CCF—our Board of Directors! This carousel showcases the talented individuals guiding our organization forward. Each photo is paired with a brief look at their unique role...

    Board of Directors at Coleen Cunningham Foundat...

    Introducing the backbone of CCF—our Board of Directors! This carousel showcases the talented individuals guiding our organization forward. Each photo is paired with a brief look at their unique role...

  • Introducing Your Guide to Atypical Parkinsonism Care: A Lifeline for Caregivers

    Introducing Your Guide to Atypical Parkinsonism...

    We’re thrilled to announce the release of Your Guide to Atypical Parkinsonism Care: Understanding and Supporting Loved Ones with PSP, MSA, CBD, and DLB, a vital new resource for anyone...

    Introducing Your Guide to Atypical Parkinsonism...

    We’re thrilled to announce the release of Your Guide to Atypical Parkinsonism Care: Understanding and Supporting Loved Ones with PSP, MSA, CBD, and DLB, a vital new resource for anyone...

  • Understanding Caregiver Burnout and Atypical Parkinsonism: Finding Relief Through Respite and Vacation Grants

    Understanding Caregiver Burnout and Atypical Pa...

    Caring for a loved one with atypical parkinsonism—conditions like Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), or Corticobasal Degeneration (CBD)—is a labor of love that often comes with immense...

    1 comment

    Understanding Caregiver Burnout and Atypical Pa...

    Caring for a loved one with atypical parkinsonism—conditions like Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), or Corticobasal Degeneration (CBD)—is a labor of love that often comes with immense...

    1 comment
1 of 4